BIP
PAHC icon

Brandes Investment Partners’s Phibro Animal Health PAHC Stock Holding History

Brandes Investment Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-38,475
Closed -$1.56M – 194
2025
Q3 		$1.56M Sell
38,475
-336,900
-90% -$11.1M 0.01% 162
2025
Q2 		$9.59M Sell
375,375
-109,379
-23% -$2.39M 0.09% 116
2025
Q1 		$10.4M Sell
484,754
-177,216
-27% -$3.96M 0.11% 112
2024
Q4 		$13.9M Sell
661,970
-822,769
-55% -$19M 0.16% 109
2024
Q3 		$33.4M Sell
1,484,739
-920,890
-38% -$17.8M 0.38% 77
2024
Q2 		$40.5M Buy
2,405,629
+29,071
+1% +$467K 0.5% 66
2024
Q1 		$30.7M Buy
2,376,558
+246,451
+12% +$2.95M 0.4% 71
2023
Q4 		$24.7M Buy
2,130,107
+256,807
+14% +$2.9M 0.37% 73
2023
Q3 		$23.9M Buy
1,873,300
+520,697
+38% +$7.38M 0.47% 67
2023
Q2 		$18.5M Buy
1,352,603
+72,304
+6% +$1.04M 0.37% 70
2023
Q1 		$19.6M Buy
1,280,299
+640,958
+100% +$9.79M 0.42% 64
2022
Q4 		$8.57M Buy
639,341
+440,521
+222% +$5.91M 0.24% 72
2022
Q3 		$2.64M Buy
198,820
+96,317
+94% +$1.66M 0.07% 117
2022
Q2 		$1.96M Buy
102,503
+7,305
+8% +$138K 0.05% 125
2022
Q1 		$1.9M Buy
95,198
+39,701
+72% +$802K 0.04% 122
2021
Q4 		$1.13M Buy
55,497
+851
+2% +$18.2K 0.02% 136
2021
Q3 		$1.18M Buy
54,646
+10,484
+24% +$252K 0.03% 124
2021
Q2 		$1.27M Buy
44,162
+5,108
+13% +$138K 0.03% 124
2021
Q1 		$958K Buy
39,054
+13,480
+53% +$304K 0.02% 124
2020
Q4 		$487K Buy
25,574
+6,934
+37% +$128K 0.01% 133
2020
Q3 		$324K Buy
18,640
+3,712
+25% +$79.2K 0.01% 137
2020
Q2 		$392K Sell
14,928
-2,091
-12% -$51.9K 0.01% 143
2020
Q1 		$411K Buy
17,019
+830
+5% +$20.3K 0.01% 126
2019
Q4 		$402K Buy
16,189
+227
+1% +$5.27K 0.01% 120
2019
Q3 		$340K Buy
15,962
+7,247
+83% +$199K 0.01% 117
2019
Q2 		$277K Buy
+8,715
New +$273K 0.01% 128
2016
Q3 		– Sell
-42,718
Closed -$797K – 200
2016
Q2 		$797K Buy
+42,718
New +$891K 0.01% 126

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brandes Investment Partners's PAHC Position: Q4 2025 in Review

Brandes Investment Partners sold out of Phibro Animal Health (PAHC) in Q4 2025, closing a stake of 38,475 shares — an estimated $1.56M sold.

Brandes Investment Partners first reported a position in PAHC in Q2 2016 and held it in 27 quarters. The position peaked at $40.5M in Q2 2024. 227 funds tracked by Wall St. Rank hold PAHC as of Q4 2025.

  • Brandes Investment Partners reported no remaining Phibro Animal Health position as of Q4 2025 after selling out during the quarter.
  • Brandes Investment Partners sold 38,475 Phibro Animal Health shares in Q4 2025, an estimated $1.56M.
  • Brandes Investment Partners first reported a position in Phibro Animal Health in Q2 2016 and held it in 27 quarters.
  • Brandes Investment Partners's Phibro Animal Health position peaked at $40.5M in Q2 2024.
  • 227 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2025.

Based on Brandes Investment Partners's 13F filing for Q4 2025, filed 11 Feb 2026.